CSF1R and neoplasm: CSF‐1R is a key target for monocytes and macrophages, and its inhibition has been shown to inhibit osteosarcoma metastasis.[22] Indeed, perioperative administration of CSF‐1R inhibitor resulted in decreased tumor burden after surgery (Figure 5F).